Name:  ___             Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
pineapple / apple
 
Attending: ___.
 
Chief Complaint:
Morbid obesity
 
Major Surgical or Invasive Procedure:
___: laparoscopic sleeve gastrectomy

 
History of Present Illness:
___ woman with class II severe obesity with weight of 
196.0 pounds as of ___ with her initial screen weight of 
206.6 pounds on ___, height of 59.5 inches and BMI of 38.9. 
 She has had previous unsuccessful weight loss efforts, however 
these attempts have failed to produce significant and/or lasting 
results. She was evaluated on our ___ clinic, and 
was admitted for a laparoscopic gastric sleeve on ___
 
Past Medical History:
- obstructive sleep apnea ___ with home sleep study ___ 
awaiting CPAP
- asthma - no flares or prednisone taper
- gastroesophageal reflux
- osteoarthritis of lower extremity joints
- back pain
- considered pre-diabetes but with normal hemoglobin A1c of 5.7%
- iron deficiency anemia with saturation of 8% 
- vitamin D deficiency
- history of ventral hernia

 
Social History:
___
Family History:
Her family history is noted for both parents living father with 
diabetes, obesity; mother with history of stroke, asthma and 
thyroid disorder, obesity; sister living with obesity.  
 
Physical Exam:
T=98.2F; BP=121/70 mmHg; HR=82x'; RR=18x'; O2 Sat=97%
 GENERAL: AOx3, NAD
 HEENT: Normocephalic, atraumatic. 
 CARDIAC: Regular rate and rhythm, no murmurs/rubs/gallops.  
 LUNGS: No respiratory distress. Clear to auscultation 
bilaterally. No wheezes, rhonchi or rales. 
 ABDOMEN:  Normal bowel sounds, non distended, non-tender to 
palpation in all four quadrants. Incisions appear clean, dry, 
and intact, without erythema or secretions.
 EXTREMITIES: No clubbing, cyanosis, or edema.  
 
Pertinent Results:
___ 05:40AM BLOOD Hct-32.3*
___ 01:10PM BLOOD Hct-33.2*
___ 05:10AM BLOOD Hct-32.1*
___ 10:15AM BLOOD Hct-35.4
 
Brief Hospital Course:
The patient presented to pre-op on ___. Pt was 
evaluated by anaesthesia and taken to the operating room for 
laparoscopic sleeve gastrectomy. There were no adverse events in 
the operating room; please see the operative note for details. 
Pt was extubated, taken to the PACU until stable, then 
transferred to the ward for observation. 

Neuro: The patient was alert and oriented throughout 
hospitalization; pain was initially managed with a PCA and then 
transitioned to oral oxycodone once tolerating a stage 2 diet. 
CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored.
Pulmonary: The patient remained stable from a pulmonary 
standpoint; vital signs were routinely monitored. Good pulmonary 
toilet, early ambulation and incentive spirometry were 
encouraged throughout hospitalization. 
GI/GU/FEN: The patient was initially kept NPO with a 
___ tube in place for decompression.  On POD1, given a 
negative intra-operative methylene blue dye test, the diet was 
advanced sequentially to a Bariatric Stage 3 diet, which was 
well tolerated. Patient's intake and output were closely 
monitored. 
ID: The patient's fever curves were closely watched for signs of 
infection, of which there were none.
HEME: The patient's blood counts were closely watched for signs 
of bleeding, of which there were none.
Prophylaxis: The patient received subcutaneous heparin and ___ 
dyne boots were used during this stay and was encouraged to get 
up and ambulate as early as possible.

At the time of discharge, the patient was doing well, afebrile 
with stable vital signs.  The patient was tolerating a stage 3 
diet, ambulating, voiding without assistance, and pain was well 
controlled.  The patient received discharge teaching and 
follow-up instructions with understanding verbalized and 
agreement with the discharge plan.

 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing, shortnes of 
breath 
2. Loratadine 10 mg PO DAILY:PRN allergies 
3. Ferrous Sulfate 325 mg PO DAILY 
4. phentermine 15 mg oral DAILY:PRN 

 
Discharge Medications:
1.  Acetaminophen (Liquid) 650 mg PO Q6H 
RX *acetaminophen 650 mg/20.3 mL 20 ml by mouth every six (6) 
hours Refills:*0 
2.  OxycoDONE Liquid ___ mg PO Q4H:PRN Pain - Moderate 
RX *oxycodone 5 mg/5 mL ___ ml by mouth every four (4) hours 
Refills:*0 
3.  Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing, shortnes of 
breath  
4.  Ferrous Sulfate 325 mg PO DAILY  
5.  Loratadine 10 mg PO DAILY:PRN allergies  
6. HELD- phentermine 15 mg oral DAILY:PRN  This medication was 
held. Do not restart phentermine until you discuss with Dr. 
___.

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Morbid obesity

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Discharge Instructions: Please call your surgeon or return to 
the Emergency Department if you develop a fever greater than 101 
F, shaking chills, chest pain, difficulty breathing, pain with 
breathing, cough, a rapid heartbeat, dizziness, severe abdominal 
pain, pain unrelieved by your pain medication, a change in the 
nature or severity of your pain, severe nausea, vomiting, 
abdominal bloating, severe diarrhea, inability to eat or drink, 
foul smelling or colorful drainage from your incisions, redness, 
swelling from your incisions, or any other symptoms which are 
concerning to you.

Diet: Stay on Stage III diet until your follow up appointment; 
please refer to your work book for detailed instructions. Do not 
self- advance your diet and avoid drinking with a straw or 
chewing gum. To avoid dehydration, remember to sip small amounts 
of fluid frequently throughout the day to reach a goal of 
approximately ___ mL per day. Please note the following signs 
of dehydration: dry mouth, rapid heartbeat, feeling dizzy or 
faint, dark colored urine, infrequent urination. 

Medication Instructions:
Please refer to the medication list provided with your discharge 
paperwork for detailed instruction regarding your home and newly 
prescribed medications.  

Some of the new medications you will be taking include:
1.  Pain medication: You will receive a prescription for liquid 
oxycodone, an opioid pain medication.  This medication will make 
you drowsy and impair your ability to drive a motor vehicle or 
operate machinery safely. You MUST refrain from such activities 
while taking these medications. You may also take acetaminophen 
(Tylenol) for pain management; do not exceed 4000 mg per 24 hour 
period.
2. Constipation: This is a common side effect of opioid pain 
medication.  If you experience constipation, please reduce or 
eliminate opioid pain medication.  You may trial 2 ounces of 
light prune juice and/or a stool softener (i.e. crushed docusate 
sodium tablets), twice daily until you resume a normal bowel 
pattern.  Please stop taking this medication if you develop 
loose stools. Please do not begin taking laxatives including 
until you have discussed it with your nurse or surgeon.
3. Antacids: You will be taking famotidine tablets, 20 mg twice 
daily, for one month. This medicine reduces stomach acid 
production. Please crush.
4. You must not use NSAIDS (non-steroidal anti-inflammatory 
drugs). Examples include, but are not limited to Aleve, 
Arthrotec, aspirin, Bufferin, diclofenac, Ecotrin, etodolac, 
ibuprofen, Indocin, indomethacin, Feldene, ketorolac, 
meclofenamate, meloxicam, Midol, Motrin, nambumetone, Naprosyn, 
Naproxen, Nuprin, oxaprozin, Piroxicam, Relafen, Toradol and 
Voltaren. These agents may cause bleeding and ulcers in your 
digestive system. If you are unclear whether a medication is 
considered an NSAID, please ask call your nurse or ask your 
pharmacist.
5.  Vitamins/ minerals: You may resume a chewable multivitamin, 
however, please discuss when to resume additional vitamin and 
mineral supplements with your bariatric dietitian.

Activity:
You should continue walking frequently throughout the day right 
after surgery; you may climb stairs.  
You may resume moderate exercise at your discretion, but avoid 
performing abdominal exercises or lifting items greater than10 
to 15 pounds for six weeks.

Wound Care:
You may remove any remaining gauze from over your incisions.  
You will have thin paper strips (Steri-Strips) over your 
incision; please, remove any remaining Steri-Strip seven to 10 
days after surgery.   
You may shower 48 hours following your surgery; avoid scrubbing 
your incisions and gently pat them dry.  Avoid tub baths or 
swimming until cleared by your surgeon. 
If there is clear drainage from your incisions, cover with 
clean, dry gauze. 
Please call the doctor if you have increased pain, swelling, 
redness, cloudy, bloody or foul smelling drainage from the 
incision sites. 
Avoid direct sun exposure to the incision area for up to 24 
months.
Do not use any ointments on the incision unless you were told 
otherwise.

 
Followup Instructions:
___